Your browser doesn't support javascript.
loading
KRAS G12D mutation predicts lower TMB and drives immune suppression in lung adenocarcinoma.
Gao, Ge; Liao, Weiting; Ma, Qizhi; Zhang, Benxia; Chen, Yue; Wang, Yongsheng.
Afiliação
  • Gao G; Department of Thoracic Oncology, Cancer Center, West China Hospital, Chengdu, Sichuan Province, 610041, China.
  • Liao W; Department of Abdominal Oncology, Cancer Center, West China Hospital, Chengdu, Sichuan Province, 610041, China.
  • Ma Q; Department of Thoracic Oncology, Cancer Center, West China Hospital, Chengdu, Sichuan Province, 610041, China.
  • Zhang B; Department of Thoracic Oncology, Cancer Center, West China Hospital, Chengdu, Sichuan Province, 610041, China.
  • Chen Y; Department of Thoracic Oncology, Cancer Center, West China Hospital, Chengdu, Sichuan Province, 610041, China.
  • Wang Y; Department of Thoracic Oncology, Cancer Center, West China Hospital, Chengdu, Sichuan Province, 610041, China; State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan Province, 610041, China. Electronic address: wangys@scu.edu.cn.
Lung Cancer ; 149: 41-45, 2020 11.
Article em En | MEDLINE | ID: mdl-32956987

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article